Arabic Arabic English English French French German German
dark

Nicox’s NCX 470 Dolomites Phase 2 Results in Glaucoma Patients to be Presented at the AAO 2021 Annual Meeting

Nicox SA, an international ophthalmology company, announced a poster presentation highlighting responder analyses results from the Dolomites Phase 2 clinical trial on NCX 470 in patients with open-angle glaucoma or ocular hypertension at the American Academy of Ophthalmology 2021Annual Meeting being held from November 12-15, 2021 in New Orleans, LA, U.S. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Benefits of Flexible Packaging for Medical Devices Now Include Child Resistance

Next Post

Hummingbird Bioscience Announces Trials in Progress Poster Presentation at the Society for Immunotherapy of Cancer 2021 36th Annual Meeting

Related Posts
Total
0
Share